Last $2.78 USD
Change Today +0.05 / 1.83%
Volume 107.1K
BTX On Other Exchanges
BTX is not on other exchanges.
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William P. Tew Ph.D.

Chief Commercial Officer, BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2012


Mr. William P. Tew, Ph.D., serves as the Chief Commercial Officer of BioTime, Inc. and served as its Vice President of Business Development since June 29, 2011. Mr. Tew Co-Founded Glycosan BioSystems, Inc., in 2006 and served as its Chief Executive Officer and President. Mr. Tew also served as Vice President of Business Development at OrthoCyte Corporation. He has more than forty years of experience in developing, commercializing research products, medical devices, sterile ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

There is no Board Members Memberships data available.


University Of Idaho

Other Affiliations*

Annual Compensation*

Total Annual Compensation$257,500

Stock Options*

All Other Compensation$11,146
Exercisable Options12,059
Unexercisable Options17,913
Total Number of Options29,972

Total Compensation*

Total Annual Cash Compensation$268,646
Total Short Term Compensation$257,500
Other Long Term Compensation$11,146
Total Calculated Compensation$268,646
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $2.78 USD +0.05


Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
John A. Scarlett M.D.Chief Executive Officer, President and Director
Geron Corporation
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
Edward H. Myles MBAPrincipal Executive Officer, Interim President, Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Corporate Development
Advanced Cell Technology Inc.
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at